Ayotunde Fadayomi, MD
Pain Medicine · Cape Girardeau, MONPI 1033671854
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,637 of the $5,225 with a category attached, or 69.6%. 10 manufacturers reported payments, led by Medtronic at 41.0% of the total. 2025 is the largest year on record at $3,892, more than ten times the $326 reported in 2023.
Across 86 payments — averaging $60.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Globus Medical$513
- Saluda Medical Americas, Inc.$319
- Vertos Medical, Inc.$217
- Stryker$202
- plus $247 from 4 others
What the payments were for
- Travel & lodging$1,58830%
- Food & beverage$3,63770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 31 | $2,144 |
| Boston Scientific | 29 | $1,583 |
| Globus Medical | 10 | $513 |
| Saluda Medical Americas, Inc. | 4 | $319 |
| Vertos Medical, Inc. | 3 | $217 |
| Stryker | 3 | $202 |
| Biotronik NRO, Inc. | 3 | $162 |
| Nevro Corp. | 1 | $52 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Vertex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$831
- GENERAL - THERAPIES$518
- WaveWriter Alpha Prime 16$388
- mild Device Kit$261
- VANTA ADAPTIVESTIM$200
- Evoke$180
- OMNICURVE$160
- INCEPTIV$146
- INTELLIS ADAPTIVESTIM$141
- Senza$129
- Prospera$124
- Intracept$114
How this compares
$5,225 in reported general payments places this provider in the 70th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 22 | $299 |
| Duloxetine Hcl | 16 | $258 |
| Tizanidine Hcl | 35 | $193 |
| Naproxen | 17 | $96 |
| Pregabalin | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Cape Girardeau
- Christopher ReisCape Girardeau$113K
- Tony AsanteCape Girardeau$5K
- Andrew WalkerCape Girardeau$5K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.